Effects of Angiotensin Converting Enzyme Inhibitors vs Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 26 Sep 2011
At a glance
- Drugs ACE inhibitors; Candesartan cilexetil
- Indications Cardiovascular disorders; Diabetes mellitus; Hyperlipidaemia; Hypertension
- Focus Therapeutic Use
- Acronyms ARBACE
- Sponsors AstraZeneca
- 26 Sep 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 09 May 2011 Actual end date (September 2010) added as reported by ClinicalTrials.gov.
- 09 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.